Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 13, 2016
- Revision received September 21, 2016
- Accepted September 22, 2016
- Published online December 5, 2016.
Copyright & Usage
Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- TIMO JOENSUU1⇑,
- GREETTA JOENSUU1,2,*,
- KALEVI KAIREMO1,3,*,
- TIMO KILJUNEN1,
- MAIGO RIENER1,
- AILI AALTONEN1,
- MARTTI ALA-OPAS1,
- AKI KANGASMÄKI1,
- TUOMO ALANKO1,
- LAURI TAIPALE1,4,
- PETTERI HERVONEN1,5,
- ANNA BÜTZOW6,
- IRENE VIRGOLINI7 and
- AKSELI HEMMINKI1,4,8
- 1Docrates Cancer Center, Helsinki, Finland
- 2Doctoral Programme of Clinical Research, University of Helsinki, Biomedicum Helsinki, Helsinki, Finland
- 3Department of Nuclear Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, U.S.A.
- 4Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland
- 5Department of Oncology, Tampere University Hospital, Tampere, Finland
- 6United MEDIX Laboratories Ltd., Espoo, Finland
- 7Department of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria
- 8Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- Correspondence to: Timo Joensuu, MD, Ph.D., Docrates Cancer Center, Saukonpaadenranta 2, FI-00180 Helsinki, Finland. Tel: +358 505001831, Fax: +358 107732099, e-mail: timo.joensuu{at}docrates.com